Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Â
colorectal ca presented by bedu mohammed.pptx
1. MANAGEMENT OF
COLORECTAL CANCER
Moderator- Prof. Berhanu Kotisso
(consultant General and Colorectal Surgeon)
presenter- Mahlet Befrdu.(GSRIII)
Sept 13/2023 G.C
2/22/2024 1
3. Overview
⢠Colorectal cancer is cancer of the colon or rectum
⢠It is the third most common cancer diagnosed in the U.S
⢠Treatment depends on the stage of the cancer
⢠Main treatments include surgery, chemotherapy, radiation
therapy, and targeted therapy
2/22/2024 3
4. Incidence
⢠Colorectal carcinoma is the third most common malignancy, and the
second leading cause of carcinoma death
⢠The American Cancer Society estimated that roughly 105,000
Americans would be diagnosed with colon cancer and 43,000 with
rectal cancer, and that 53,200 deaths would be attributed to these
cancers in the year 2020
⢠The incidence and mortality has declined in recent years most likely
due to increased screening
⢠The overall lifetime risk of developing colorectal cancer is 4.7% in men
and 4.4% in women
2/22/2024 4
5. ⢠In the United States, over the past several decades the survival rate
has improved for each stage
⢠The current 5-year relative survival for people with
⢠stage I colon cancer is about 92%,
⢠stage IIA 87%,
⢠stage IIB 63%,
⢠stage IIIA 89%, stage IIIB 72%,
⢠stage IIIC 53%, and
⢠stage IV 11%
2/22/2024 5
6. ⢠Limited data suggests the incidence of colorectal cancer in
Ethiopia is relatively low compared to other African countries,
but still a growing problem
⢠Ethiopia is estimated to have an age-standardized incidence
rate for colorectal cancer of around 6 cases per 100,000
population per year
2/22/2024 6
11. Risk Factors
⢠Increasing age
⢠Gender
⢠Family history of colorectal cancer
⢠Personal history of colorectal polyps or inflammatory bowel
disease
⢠Lifestyle factors like smoking, heavy alcohol use, obesity, red
and processed meat consumption
⢠Low fiber diet
⢠Pelvic radiation
2/22/2024 11
13. Site
⢠The distribution of carcinoma in the various segments of the large
bowel has been the subject of several detailed clinical studies
⢠Studies have shown that over the past 50 years there has been a
gradual shift in the location of carcinomas from the rectum and left
colon toward the right colon
2/22/2024 13
14. Geographic Distribution
⢠There is a wide variation of the incidence of colorectal carcinoma in
different countries
⢠In general, countries of the Western world have the highest incidence
of colorectal carcinoma, and these include Scotland, Luxembourg,
Czechoslovakia, New Zealand, Denmark, and Hungary
2/22/2024 14
15. Etiology and Pathogenesis
⢠A number of factors have been considered important in its causation, and
certain clinical conditions are considered precursors of carcinoma
⢠PolypâCancer Sequence
⢠Inflammatory Bowel Disease
⢠Genetics
⢠Dietary Factors
⢠Alcohol Ingestion and smoking
2/22/2024 15
19. Modes of Spread
⢠Direct continuity
⢠Transperitoneal spread,
⢠Lymphatic spread,
⢠Hematogenous spread, and implantation
2/22/2024 19
20. Site of Spread
⢠For every 100 patients with intestinal carcinoma, approximately on half will
be cured by operation and 5 will die from lymphatic spread, 10 from local
recurrence, and 35 from blood-borne metastases
⢠The organs most frequently involved are the
⢠Liver (77%),
⢠Lungs (15%),
⢠Bones (5%), and
⢠Brain (5%)
2/22/2024 20
25. ⢠The International Union Against Cancer, the American Joint
Committee on Cancer, a National Cancer Institute consensus panel,
and the College of American Pathologists have all recommended
evaluation of at least 12 nodes to ensure adequate sampling
26. ⢠The rate of growth of an individual carcinoma is almost certainly the
most important prognostic discriminant
⢠Colorectal carcinomas are relatively slow-growing neoplasms, and
metastases occur relatively late
27. Clinical Features and Symptoms
⢠Patients with carcinoma of the large intestine may present in one of
three characteristic ways:
⢠insidious onset of chronic symptoms,
⢠acute intestinal obstruction,
⢠or perforation with peritonitis.
28. ⢠Depending on the location in the bowel, one or another of the
following symptoms may predominate
⢠Bleeding is probably the most common symptom of large bowel
malignancy
⢠may be occult, as is often the case in right-sided lesions,
⢠or overt, being either bright red, dark purple, or even black, depending on the
location in the bowel
29. ⢠The second most common presenting symptom is probably a change
in bowel habits, either constipation or diarrhea
⢠Lesions in the proximal colon may not result in a change in bowel
symptoms until they are very far advanced
⢠Lesions in the distal colon are more likely to manifest in symptoms
since the stool is more formed in consistency and the bowel lumen is
narrower
⢠A progressive narrowing of the caliber of the stool may be reported in
the case of a compromised lumen
30. ⢠Pain may occur with almost equal frequency as the preceding
symptom
⢠Abdominal pain may be vague and poorly localized, or it may result
from a partially obstructing lesion of the colon
⢠Rectal pain does not occur with carcinoma unless there is sacral nerve
root or sciatic nerve involvement
⢠tenesmus may occur with rectal carcinoma
⢠Back pain is a late sign of penetration of retroperitoneal structures
31. ⢠Other symptoms include
⢠mucus discharge
⢠weight loss
⢠Nonspecific symptoms of general impairment of health
⢠loss of strength, anemia, and sporadic fever
⢠carcinoma of the cecum may present with the signs and symptoms of acute
appendicitis
⢠Iron deficiency anemia
32. ⢠In the report of the Commission on Cancer, in which 16,527 patients were diagnosed with
carcinoma of the colon, the presenting symptoms in order of frequency were
⢠abdominal pain (40.5%),
⢠change in bowel habits (33.2%),
⢠rectal bleeding (28.5%),
⢠occult bleeding (34.3%),
⢠malaise (16%),
⢠bowel obstruction (14.9%),
⢠pelvic pain (3.4%),
⢠emergency presentation (6.6%), and jaundice (1%)
33. General and Abdominal Examinations
⢠Any obvious excess weight loss may indicate advanced disease
⢠Pallor
⢠The assessment may help in evaluating the patientâs fitness for
operation
⢠mass may be present and may indicate the primary malignancy or
possible metastatic disease
34. ⢠The liver may be enlarged
⢠Ascites
⢠Abdominal distention
⢠Inguinal and left supraclavicular lymphadenopathy
⢠Peritonitis
35. ⢠Digital Rectal Examination will not identify the presence of a colon carcinoma, it
should reveal the presence of a rectal lesion
⢠Sometimes a sigmoid carcinoma that hangs down into the cul-de-sac may be
palpable
⢠Extraintestinal Manifestations
⢠acanthosis nigricans,
⢠dermatomyositis,
⢠pemphigoid
36. ⢠Synchronous Carcinomas are not uncommon, and in recent reviews
the incidence was found to range from 2 to 8% in colon carcinoma
patients
⢠Colonoscopy performed preoperatively in patients undergoing
elective resection is the optimal method for assessing the unresected
colon for synchronous lesions
37. Complications
⢠Obstruction
⢠Depending on the macroscopic features and location of the
malignancy, interference with the passage of intestinal contents may
occur
⢠Carcinoma is the most common cause of large bowel obstruction,
contributing to 60% of cases in the elderly
⢠Incidences ranged from 7 to 29%
38. ⢠Complete obstruction of the colon from carcinoma is often entirely
insidious in its onset
⢠Nausea and vomiting with progressive symptoms of obstipation
⢠patients may present with sudden, severe, colicky abdominal pain
that persists, and investigation may reveal a complete obstruction
39. ⢠On examination, the patientâs general condition usually is found to be
good, because dehydration and electrolyte depletion are often late
phenomena
⢠abdomen reveals that it is distended and tympanitic but not tender
Hyperactive peristalsis may be present
40. ⢠Sigmoidoscopy
⢠Plain X-ray
⢠nonspecific type of colitis may develop proximal to an obstructing
carcinoma of the colon
41. Perforation
⢠The incidence of perforation associated with carcinoma of the colon is
in the 6 to 12%
⢠peritonitis,
⢠abscess formation,
⢠adherence to a neighboring structure, or
⢠fistulous communication into a viscus
42. ⢠Patients with obstruction and a proximal perforation present as
desperately ill individuals with generalized peritonitis, dehydration,
and electrolyte depletion
⢠Immediate exploratory laparotomy is demanded
⢠Patients without obstruction but with perforation of the carcinoma
are also gravely ill and require immediate laparotomy after some
correction of dehydration and electrolyte depletion
⢠Patients without obstruction but with perforation of a carcinoma may
present with a localized peritonitis
43. ⢠Bleeding
⢠Is a common symptom of colorectal carcinoma, but massive bleeding
is an uncommon presentation
44. Diagnosis
⢠occult blood testing and flexible fiberoptic sigmoidoscopy is the
minimum current recommendation
⢠Colonoscopy is ideal and preferable
45. Differential diagnosis
⢠Inflammatory bowel disease,
either of the nonspecific type
⢠ulcerative colitis
⢠or Crohnâs disease, amebiasis,
actinomycosis, or tuberculosis
⢠ischemic strictures
⢠Acute abdomen may be
confused
⢠Diverticulitis or appendicitis with
abscess
⢠Crohnâs disease, foreign body
perforation
⢠acute obstruction, volvulus,
diverticulitis
⢠Extrinsic pressure from a
metastatic carcinoma
46. Investigations
⢠Blood Markers
⢠Whole blood count
⢠Liver Function Tests
⢠Carcinoembryonic Antigen
⢠Normal concentrations of CEA are 2.5 to 5.0 ng/mL, depending on the assay
used
⢠80% or more of patients with advanced colonic adenocarcinoma have
circulating CEA, the CEA assay should not be used as the sole diagnostic test
for suspected carcinoma
⢠CEA levels are not presently useful for distinguishing locally invasive polyps
from benign lesions
2/22/2024 46
47. ⢠Preoperative serum CEA levels in diagnosed colorectal carcinoma are
elevated in 40 to 70% of patients
⢠Correlate inversely with the grade of the carcinoma and directly with
the pathologic stage
⢠The CEA is elevated in 95% of patients with well-differentiated
lesions, while it is elevated in as few as 30% of those with poorly
differentiated adenocarcinomas
2/22/2024 47
48. ⢠The higher the preoperative CEA level, the greater the likelihood of a
postoperative recurrence
⢠An increase in the blood CEA concentration in a patient after
apparently successful surgical treatment for carcinoma has repeatedly
been shown to signal a recurrence of the carcinoma
2/22/2024 48
49. ⢠Occult Blood Testing
⢠Endoscopy
⢠Sigmoidoscopy (flexible, rigid)
⢠Colonoscopy
⢠Radiology
⢠Barium Enema (In the past) an annular, or napkin ring, apple coreâ
⢠Intravenous Pyelography
⢠Ultrasonography
⢠Computed Tomography
⢠Magnetic Resonance Imaging
⢠Biopsy
2/22/2024 49
50. Management of colorectal cancer
ďśMultidisciplinary team (MDT) approach
⢠Ideal for the management of patients with colorectal cancer
especially in locally advanced and recurrent CRC.
⢠Involvement of multiple subspecialists
⢠MDT team is involved in
⢠Staging process
⢠Pathologic evaluation
⢠Type of surgery needed and for neoadjuvant and adjuvant therapy
52. Surgical treatment of colonic ca
⢠Preoperative Evaluation
⢠Bowel Preparation
⢠Curative Resection
2/22/2024 52
53. ⢠When the abdomen has been opened, attention should be directed to
ruling out the presence of metastatic disease, with special attention
given to the liver and the pelvis
2/22/2024 53
54. Principles of Resection
⢠Removal of the primary lesion with adequate margin, including the
areas of lymphatic drainage
⢠En bloc resection of involved structures is firmly established
2/22/2024 54
61. ⢠Complete mesocolic excision (CME) includes dissection in the
mesocolic plane with central vascular ligation, has been proposed as a
means of improving lymph node yield and subsequent outcomes
⢠The goal is to remove the entirety of the mesocolon along
embryologic tissue planes with transection of the critical vasculature
at the origin
2/22/2024 61
62. Invasion of Adjacent Viscera
⢠Carcinoma can becomes attached to the abdominal wall or the
adjacent viscera, such as the small bowel, urinary bladder, uterus,
stomach, spleen, ureter, or duodenum
⢠Combined or staged liver resection
⢠Lung metastasis
⢠Palliative resections
2/22/2024 62
68. Local Staging
⢠The two imaging modalities that are the most useful for local staging
of rectal adenocarcinoma are transrectal ultrasound (TRUS) and MRI
⢠CT of the pelvis can define tumor invasion into surrounding structures
for larger tumors, but does not adequately assess depth of invasion
for smaller tumors
2/22/2024 68
70. ⢠Multidisciplinary Tumor Board
⢠All patients with rectal cancer should be discussed upon
prentation
⢠surgeons, radiologists, pathologists, medical oncologists, and
⢠radiation oncologists
2/22/2024 70
71. ⢠Neoadjuvant Therapy
⢠Indications
⢠The use of neoadjuvant therapy has led to a significant reduction in local
recurrence rates for patients with resectable adenocarcinoma of the
rectum
⢠At present, the current standard of care for neoadjuvant therapy includes
⢠long-course chemoradiation (50.4Gy) delivered in 28 fractions with concurrent
⢠fluoropyrimidine-based radio-sensitizing chemotherapy and surgery after 6 to 8
weeks,
⢠or short-course preoperative radiotherapy delivered as 25 Gy in 5 fractions over 1
week, followed by surgery within a week of completion of therapy
2/22/2024 71
76. ďLow anterior resection
withTME
⢠Most important factor is the level
of the lesion, with safe distal
margin of resection 1-2cm.
⢠The only absolute
contraindication for a low
colorectal or coloanal
anastomosis are
⢠Invasion into the anal canal
⢠Invasion of the sphincter mechanism
77. ⢠Total Mesorectal Excision
Dissection in the avascular âholy planeâ between the visceral and
parietal layers of the endopelvic fascia ensuring en bloc removal of the
primary tumor and associated mesentery, lymphatics, vascular, and
perineural tumor deposits, as well as preserving autonomic nerve
and reducing bleeding
2/22/2024 77
82. ⢠Distal Margin
⢠Distal intramural tumor spread is uncommon and is found beyond 1 cm from the
primary tumor in less than 10% of cases
⢠A 2-cm distal mural margin is usually adequate for distal rectal cancers when
combined with TME. A 1-cm distal mural margin is generally acceptable for
cancers located at or below the mesorectal margin recommended in the most
recent ASCRS practice parameters for rectal cancer
2/22/2024 82
83. ⢠Abdominoperineal Excision
⢠Tumors that involve the distal mesorectal fascia, levator muscle, or
sphincter complex may require an APE to obtain a clear radial or distal
margin
2/22/2024 83
85. ⢠Three types of APE can be defined based on patient and tumor
related factors
⢠intersphincteric APE,
⢠extralevator APE (ELAPE), and
⢠ischioanal APE
⢠For all three types, the abdominal portion is identical
⢠Pathologic macroscopic grading of the resected sphincter complex
(valid for ELAPE and ischioanal APE only) is performed in similar
manner graded as the mesorectum and is divided into three
categories: extralevator, sphincteric, and intrasphincteric/submucosal
planes
2/22/2024 85
88. Emergency
⢠Bleeding,
⢠radiation
⢠Obstruction,
⢠obstruction due to extraperitoneal rectal cancer, decompression with a
proximal diverting stoma should be considered and
⢠Perforation
⢠control the septic source, resection with or without anastomosis according to
oncologic Principles
⢠proximal to the tumor, an extended resection
2/22/2024 88
89. ďśPostoperative care
⢠Diet
⢠Drainage
⢠Urinary catheter
ďścomplications
⢠Urinary complications(50%)
⢠Perineal wound infections(16%)
⢠Leaks from stoma
appliance(66%)
⢠Sexual dysfunction (67%)
⢠Stoma complications
90. ⢠Postoperative Chemoradiation
⢠Patients with clinical stage I tumors who undergo up front surgery and are
upstaged to stage II or III,
⢠or patients who undergo upfront surgery for preoperative low-risk T3N0
tumors who have a positive CRM, incomplete TME, or residual disease after
surgery
⢠should be considered for postoperative chemoradiation to reduce the
risk of locoregional recurrence and distant metastasis.
2/22/2024 90
93. References
⢠Gordon principles and practice of Surgery for the Colon Rectum and
Anus, 4th edition
⢠Schwartzâs principle of surgery, 11th edition
⢠Maingotâs Abdominal Operations, 13th edition
⢠NCCN Guideline Version 2023
⢠Sabiston Textbook of Surgery, 20th edition
⢠Uptodate.uptodate.com
2/22/2024 93
In Western countries like the US and Europe, the 5-year relative survival rate for colorectal cancer is around 65%. In Ethiopia, limited data suggests 5-year survival could be as low as 15-30%.
This large survival gap is partly due to more advanced stage at diagnosis in Ethiopia. In the West, around 40% of cases are diagnosed at an early, localized stage due to screening programs. In Ethiopia, over 80% of patients present at late, metastatic stages when outcomes are poorer
In Ethiopia, the five most common cancer incidence cases were leukemia (8310 [95% UI 4270â12440]), cervical cancer (6570 [95% UI 4470â10640]), breast cancer (5900 [95% UI 4640â7420]), colon and rectum cancer (3200 [95% UI 2400â4460]), and stomach cancer (2580 [95% UI 2100â3230]). In 2019, the highest age-standardised incidence rate was observed in breast (12.5 [95% UI 10.1â15.3]), cervical cancer (12.1 [95% UI 8.4â19.3]), leukemia (9.5 [95% UI 5.3â13.4]), CRC (7.7 [95% UI 5.8â10.7]), and prostate cancer 7.5 (95% UI 4â12.3) per 100,000,
Family history of colorectal cancer
risk to be increased twofold to fourfold Furthermore, people who have a first-degree relative with colorectal carcinoma are estimated to have an average onset of colorectal carcinoma about 10 years earlier than people with sporadic colorectal carcinoma
Such findings imply that methods for the early detection and screening of large bowel carcinoma should be directed at the entire colon rather than being
limited to the distal 25 cm of the large intestine. Qing et al in a comparison between American and Chinese patients found lesions in 36.3% of white patients versus 26.0% of Asian patients, while carcinomas of the rectum were found in 63.7% of white patients and 74% of Asian patients. The rightward shift has continued in recent decades in the United States14 and Japan
Countries with the lowest incidence include India, El Salvador,
Kuwait, Martinique, Poland, and Mexico. The United States and Canada hold an intermediate position.3,4 In large countries ex-
tending over a wide range of latitudes, there may be considerable regional differences that mimic international variations
Although colorectal carcinoma, complicating ulcerative colitis and Crohnâs disease, only accounts for 1 to 2% of all cases of colorectal carcinoma in the general population, it is considered a serious complication of the disease and accounts for approximately 15% of all deaths in inflammatory bowel disease patients
Recent figures suggest that the risk of colon carcinoma for people with inflammatory bowel disease increases by 0.5 to 1.0% yearly, 8 to 10 years after diagnosis
The incidence of colorectal carcinoma in patients with Crohnâs disease has been reported as being 4 to 20 times greater than the general population
Smoking for 20 years has a strong relation to adenomas, but an induction period of at least 35 years is necessary for colorectal carcinoma
A relationship between alcohol ingestion and development of colorectal carcinoma has been reported (OR, 2.6),109 specifically the development of rectal carcinoma in association with beer consumption. Daily alcohol drinkers experience a twofold increase in risk of colorectal carcinomas.130 The positive association had been accounted for primarily by an increased risk of carcinoma in men whose monthly consumption of beer was 15 L or more. Beer drinking increases the risk 1.3 to 2.4 time
the risk of sigmoid carcinoma has been estimated to be any where from 8.5 to 10.5 and 80 to 550 times greater in patients with ureterosigmoidostomy than in the normal population The interval between the implantation of ureters and the occurrence of colonic carcinoma varies from 5 to 41 years.
A suggested explanation is that, although before cholecystectomy the bile acid pool circulates two or three times per meal, after cholecystectomy the pool circulates even during fasting. This enhanced circulation results in increased exposure of bile acids to the degrading action of intestinal bacteria, a step in the formation of known carcinogens
Tumors arising from the LOH pathway tend to occur in the more distal colon, often have chromosomal aneuploidy, and are associated with a poorer prognosis
Intramural spread of the carcinoma occurs more rapidly in the transverse than the longitudinal axis of the colon and has been estimated to proceed roughly at the rate of one quarter of the bowel circumference every 6 months
It is unusual for microscopic spread to occur more than 1 cm beyond the grossly visible disease.
The spleen, kidneys, pancreas, adrenals ,breast, thyroid, and skin are rarely involved
Even the trachea, tonsils, skeletal muscle, urethra, oral cavity, penis, and nail bed have become involved
By definition, the lesion must penetrate through the muscularis mucosa for it to be considered an invasive carcinoma
All too often, the bleeding is attributed by the patient, and regrettably by the physician as well, to hemorrhoids. Despite the fact that the most common cause of rectal bleeding is hemorrhoids, bleeding cannot be dismissed lightly, especially in a middle aged or older individual. It has been estimated that visible blood per rectum occurs in 10% of the adult population over the age of 30 years
The absolute frequency of defecation is not important, but a deviation from what is normal for a given individual may signal the presence of an intestinal neoplasm
The latter type of pain is generally colicky in nature and may be associated with obstructive symptoms of bloating, nausea, and even vomiting.
when associated with a carcinoma, weight loss is usually a sign of advanced disease and bodes a poor prognosis.
Iron deficiency anemia is a recognized complication of colorectal carcinoma, especially with right-sided lesions, and failure to investigate the anemia in older patients may lead to a delay in diagnosis
Bladder involvement may result in urinary frequency, suprapubic pressure, and even pneumaturia if a sigmoidovesical fistula has developed
The general examination may be a guide to the patientâs state of nutrition.
Usually, the general abdominal examination fails to reveal
significant abnormalities.
Halak et al308 reported on the incidence of synchronous colorectal and renal carcinomas and reviewed the literature on that issue
If technically and logistically possible, it would be ideal for all patients about to undergo elective resection of carcinoma to have a preoperative colonoscopic examination.
If not possible, it is suggested that patients should have postoperative colonoscopy.male gender (OR, 1.94), personal history of colorectal adenoma (OR,3.39), proximal location of primary carcinoma (OR, 1.4), TNM stage II (OR, 1.31), mucinous carcinoma (OR, 1.89), and family history of gastric carcinoma
In the right colon, carcinomas are usually polypoid, and because of the liquid nature of the intestinal contents, obstruction is unlikely unless it involves the critical ileocecal valve, in which case obstruction may supervene.
In the left colon, where the intestinal contents are solid and the nature of the malignancy is more inclined to be annular, occlusion is more likely
The patient often has had progressive difficulty in moving his or her bowels and
has taken increasing doses of laxatives until the abdomen has
become more distended with pain and eventual obstipation
It is unlikely that an abdominal mass will be felt in the presence of a distended abdomen. Digital examination may reveal a balloon type rectum and, in the exceptional case, a palpable carcinoma may be present. A mass in the cul de sac may be appreciated, representing either a sigmoid loop that is hanging down or a cul de sac implant
films of the abdomen will reveal the presence of obstruction and indicate its level. The amount of small bowel distention will depend on the competence of the ileocecal valve. The presence of an obstructing carcinoma can be confirmed with an emergency barium enema study
The National Surgical Adjuvant Breast and Bowel Project (NSABP) trials have suggested that obstructing carcinomas in the right colon carry a more significant risk of recurrence and carcinoma-related mortality than obstructing carcinomas in the left colon
Perforation is found in conjunction with obstruction in approximately 1% of patients with colorectal carcinoma
In patients with obstruction, concurrent perforation is found in 12 to 19% of patients
If acute obstruction supervenes in the middle or distal colon, the cecum may perforate. However, the most common form of perforation is associated with the carcinoma itself
Under these circumstances it may be confused with diverticulitis if the sigmoid colon is involved, or with appendicitis or Crohnâs disease if the right colon is involved
In a case of carcinoma of the colon the patientâs history may not be helpful. Consequently, early diagnosis may depend on screening, which may be directed at the identification of high-risk groups, the use of screening tests, and the investigation of patients with positive screening test results
a host of conditions may be considered, depending on the predominant symptom complex with which the patient presents
The CEA molecule is considered an oncodevelopmental human marker of neoplasia initially found in adenocarcinomas of the human digestive system. The molecule has a nominal molecular mass of 180 kDa
use of the CEA assay have included detection, diagnosis, monitoring, staging and classification (prognosis), pathology, localization, and therapy
Elevated CEA levels have been described in advanced breast carcinoma, pancreatic carcinoma, lung carcinoma, and other noncolonic adenocarcinomas, but
they do not detect early stages of these diseases
most studies report that a high preoperative CEA level is indicative of a poor prognosis.
After apparently complete surgical resection of colorectal carcinoma, the blood CEA concentration, if elevated before operation, decreases to the normal range in nearly all patients. The decrease usually occurs within 1 month but sometimes takes up to 4 months. If levels fail to decrease to the normal range, it is
likely that the resection has been incomplete or that the carcinoma has already metastasized
Occult blood determinations are of value in the screening setting however, for patients who have symptoms that are suggestive of large bowel disease, occult blood testing is inadequate. Certainly patients who relate a history of rectal bleeding do not need occult blood testing to confirm its presence
The appearance of rectal carcinoma is usually quite distinctive. A protruding mass into the lumen may be seen, but more characteristically a raised everted edge with a central, sometimes necrotic, sloughing base will be noted. The distance from the lower edge of the lesion to the anal verge should be carefully determined because it may be crucial in deciding whether intestinal continuity can be restored. Two points also should be noted: which wall the lesion is located on and whether the lesion is annular
CT scanning of the abdomen and pelvis delineates the extent of the disease and excludes metastatic disease in the liver and helps in the preoperative planning of the extent of the operation. The authors concluded that CT eliminates the need for a preoperative IVP, improves the preoperative staging of metastatic disease, and provides a baseline for comparison during the postoperative follow-up if recurrence is suspected or adjuvant therapy is planned.
CT and MRI exhibited accuracies of 62 and 64%, respectively, in assessment of lymph node involvement with sensitivities of 48 and 22%, respectively. The accuracy of MRI and CT in the evaluation of liver metastases was equivalent (85%).
right hemicolectomy, an oblique right-sided abdominal incision
transverse colon lesions, a supraumbilical transverse incision
Left subcostal transverse incision combined with the right lateral
position.
left-sided colonic lesions, a subumbilical transverse incision can be used
For emergency operations, a midline incision seems the access of choice
Lesions greater than 1 cm in diameter can be detected in 95% of cases, and those between 0.5 and 1.0 cm in 66% of cases. After assessment of the abdomen, attention is focused on the primary lesion to determine its resectability.
As with the technique for right hemicolectomy, some surgeons advocate ligation and division of the blood supply prior to any other manipulation, but the
same general principles pertain
For lesions located in the cecum or the ascending colon, a right hemicolectomy to encompass the bowel served by the ileocolic, right colic, and right branch of the midcolic vessels is Recommended
Hepatic flexure, a more extended resection of the transverse colon is indicated
For lesions in the transverse colon, depending on the portion involved, a segment of bowel is removed
Splenic flexure lesions require removal of the distal half of the transverse colon and the descending colon
Sigmoid lesions are appropriately treated by excision of the sigmoid colon
Open Right Hemicolectomy
patient is positioned supine with arms out.
midline incision A self-retaining retractor is placed, and the abdomen is
thoroughly explored
incises the lateral peritoneal reflection (white line of Toldt) with cautery The right colon is mobilized off the retroperitoneum, including Gerota fascia, the duodenum, and the head of the pancreas. Care is taken to avoid traction injury to the small veins around the head of the pancreas, and bleeding at this site often requires suture ligatures for control
The cecum and terminal ileum are then dissected anteromedially with care to identify the right gonadal vessels and ureter.
This dissection continues to the third portion of duodenum
The hepatic flexure is taken down similarly with cautery
The right portion of omentum is generally resected en bloc and divided below the right gastroepiploic arcade.
The omentum is dissected off the mid-transverse colon and divided between clamps and ties or with the use of a vessel sealing device
The lesser sac is entered. Next, the ileocolic pedicle is identified by retracting the cecum to the right.
The ileocolic vessels are located at the caudal portion of the root of the mesentery.
The right colic vessels are variable; they are predominantly a branch of the ileocolic pedicle but in rare circumstances are a separate takeoff from the superior mesenteric artery and vein.
The ileocolic vessel is cleared at their junction with the superior mesenteric artery and vein, ligated, and divided between clamps and ties or with a vessel-sealing device
Dissection continues along the superior mesenteric vein, consistent with the principles of total mesocolic excision, and the middle colic pedicle is identified. Care is taken to resect the right colon mesentery without breach of the visceral fascia. In a standard resection, the right branch of the middle colic pedicle is ligated, and dissection continues along the mesentery to the proximal/mid-transverse colon. In an extended resection, the middle colic vessels are ligated at their origin with anastomosis between the terminal ileum and distal transverse colon or descending colon
An anastomosis-in-continuity is performed with creation of an enterotomy and a colostomy
The surgical group in Erlangen, Germany, reported 5-year survival rates of >85% for patients undergoing CME
. It is estimated that such attachment occurs in approximately 10% of all
patients with colon carcinomas with a reported range of 3.1 to 16.7%
âTo extreme diseases, extreme remedies.â In order
to perform an adequate curative operation, it sometimes be-
comes necessary to excise en bloc all or part of the attached vis-
cus (âś Fig. 22.30). Often, these adhesions are inflammatory in
nature and not caused by malignant infiltration, so the prognosis
frequently is better than might have been anticipated originally
(âś Table 22.5). With this knowledge, the surgeon should not hes-
itate to resect attached structures
#25. In patients with colon cancer and resectable liver metastasis, a single âcombinedâ operation is generally recommended for relatively low complexity operations and sequential or âstagedâ operations are generally recommended for higher complexity cases. Grade of recommendation: weak recommendation based on moderate quality evidence,
#26. In patients with resectable colon cancer lung metastasis, resection of the lung lesions should be considered as it may prolong survival. Weak recommendation based on moderate-quality evidence, 2B. Mismatch repair #32. In patients with stage IV (dMMR or MSI-H colon cancer, immunotherapy with antibody to PD-L1 or PD-1 should be cons
If unexpected metastatic disease is encountered at the time of a laparotomy, the decision about whether to proceed with resection of the primary tumor depends on the volume of distant disease, location and size of the primary tumor, the operation required to remove the primary tumor, and the operative
approach. If the metastatic disease is low volume (isolated or potentially resectable liver lesions) and the resection of the primary tumor is straightforward (segmental abdominal colectomy), it is probably reasonable to proceed with resection.
On the other hand, if the metastatic disease is high volume (carcinomatosis), especially if the primary tumor is minimally symptomatic, the operation should be aborted in order to facilitate early systemic chemotherapy
In contrast to
overall trends, rectal cancer incidence increased by 1.8% annually in younger adults between 1990 and 2013.1
Both modalities are more accurate than CT for assessing the depth of tumor invasion, nodal staging, and assessment of the circumferential resection margin (CRM). CT also does not accurately diagnose malignant perirectal adenopathy, with a sensitivity of only 49%.45 The utility of preoperative CT is to detect tumor-related complications such as perforation, malignant fistula, or obstruction.
Management decisions to proceed with neoadjuvant therapy, upfront surgery, or other strategies are decided on using a consensus multidisciplinary team approach. was associated with lower incidences of permanent stoma and local recurrence, improved delivery of evidence-based care, and, most importantly, better overall survival.
The best regimen for neoadjuvant therapy has not been determined, with significant variability internationally. In the United States, long-course chemoradiation is the favored approach for any patient with an indication for neoadjuvant therapy, whereas in Europe, short-course radiotherapy is preferred. What is clear from the data is that both reduce the risk of local recurrence by approximately 50% without major differences in disease free and overall survival, especially in patients undergoing proctectomy according to TME principles.
One potential benefit of long-course chemoradiation is the potential for significant tumor regression with 10 to 15% incidence of complete pathologic response, which may favorably impact prognosis. An overview of the seminal randomized controlled trials that have influenced current neoadjuvant management will be reviewed below.
The benefits of an approximate 50% reduction in local recurrence for both neoadjuvant long-course chemoradiation or short-course radiotherapy and the 10 to 15% pathologic complete response is associated with significant adverse events that result from these therapies.
Early rectal cancer is defined as well to moderately differentiated clinical T1 tumors with absence of lymphovascular and perineural invasion. These patients are at the lowest risk of lymph node metastasis and local recurrence and therefore are amenable for local excision with curative intent.
The main controversy surrounding management of early rectal cancer is trade-off between the excellent oncologic outcomes associated with radical surgery for T1 tumors (with 5-year survival approaching 90%) and the lower perioperative and long-term morbidity associated with local excision, as radical surgery is associated with significant perioperative complications and long-term functional impairments.
Local excision is an acceptable curative-intent treatment
in highly selected patients with cT1N0 rectal cancer with
favorable clinical and histological features
it does not adequately remove or pathologically
stage the mesorectal lymph nodes. The risk of occult nodal
metastasis from T1 lesions ranges from 6% to 11% with
greater risk associated with pathologic features such as
SM3 invasion, poor differentiation, tumor budding, and
lymphovascular or perineural invasion
The rate of local recurrence following local excision
varies from 7% to 21% for T1 lesions and is consist-
ently higher than that after radical resection
Local recurrence rate in Healdâs TME series of 115 curative-intent rectal cancer resections was 2.7% after a mean follow-up of 4.2 years
Prior to TME, rectal mobilization by blunt dissection, which leaves much of the mesorectum behind, was associated with local recurrence rates as high as 30 to 40%
TaTME
A TME is not oncologically necessary for tumors of the rectosigmoid and upper rectum.
A TME by definition requires removal of the entire mesorectal envelope down to the levators and subsequent low pelvic anastomosis. However, low anastomoses are associated with increased risk of anastomotic leak,as well as
worse intestinal functional outcomes.
Furthermore, distal mesorectal metastatic nodal deposits are rarely found beyond 5 cm.
Consequently, tumors in the upper rectum can be managed by a tumor-specific mesorectal excision (TSME). The
ASCRS practice parameters recommended mesorectal excision
no less than 5 cm beyond the lowest extent of the tumor
Once the posterior mobilization is completed, the dissection proceeds laterally in the same areolar plane until it is completed circumferentially (âśFig. 24.8).
Dissection in the correct plane avoids injury to the presacral plexus with potentially major hemorrhage, as well as minimizes sexual
dysfunction due to inadvertent nervous injury.
The autonomic nerves of the inferior hypogastric plexus lie superficial to the endopelvic fascia and are at highest risk of injury during the postero-lateral pelvic mobilization.
Old surgical dogma necessitated a 5-cm distal margin, but early work in the pre TME era from Williams et al and Pollet and Nicholls271 showed
that there was no difference in local recurrence between patients with a 2- versus 5-cm distal margin
For curative resection of tumors of the upper third of the rectum, a tumor-specific mesorectal excision should typically be performed as part of a low anterior resection (LAR) with the mesorectum divided, ideally, at least 5 cm below the distal margin of the tumor.
For tumors of the middle and lower thirds of the rectum, total mesorectal excision (TME) should typically be performed as a part
of an ultralow anterior resection or abdominoperineal resection (APR).
A 2-cm distal mural margin will remove all microscopic tumor in the majority of cases and is
Since the introduction of proctectomy according to TME principles, sphincter preservation, urogenital function, and local recurrence have
improved. Yet, oncologic outcomes for patients undergoing abdominoperineal excision (APE) for low rectal cancer in the TME era are still inferior to those under going low anterior resection
TME principles dictate meticulous sharp dissection in the areolar tissue enveloping the mesorectal fascia to the top of the anorectal ring, at which point
the mesorectum is separated off of the levator muscles.
The perineal portion of the APE follows the external sphincter until the top of the anal canal, at which point the levators are divided close to the rectal wall. This approach typically results in a âwaistâ at this level, which is often where the tumor is situated
and where the mesorectum is the thinnest. The waisting effect increases the risk of bowel perforation and CRM involvement, since the sphincter muscles form the CRM below the level of the levators
Perineal dissection-A marking pen is used to draw an ellipse 2 cm outside the superficial
external sphincter and extending from the perineal body anteriorly, coccyx
posteriorly, and ischial tuberosities laterally.
Urinary complications can be as high
as 50% and perineal wound infections 16%. In addition to these perioperative
problems, significant long-term morbidity is associated with a permanent
colostomy.
It is recommended to routinely create a diverting loop ileostomy after primary anastomosis for patients with a low pelvic anastomosis after neoadjuvant radio-
therapy, intraoperative anastomotic complications, and those with risk factors for poor wound healing. It should be strongly considered for patients who may not tolerate the physiologic sequelae of an anastomotic leak or those in whom the potential impact of delaying adjuvant systemic therapy outweighs the
potential morbidity of a stoma. If proximal diversion is undertaken, a loop ileostomy is preferred over a loop colostomy due to less stoma prolapse and ease of closure.
. Up to 20% of all patients with colorectal cancer present as emergencies and the management of such patients can be challenging because of competing treatment priorities and the generally higher risk of morbidity
Among patients with nonmetastatic cancer whose disease is amenable to curative intent treatment, optimal management should typically address immediate threats to life while preserving the opportunity to pursue multimodality treatment, as indicated. Emergent resection of a locally advanced rectal cancer omitting multimodality therapy should typically be avoided because this may potentially compromise oncologic outcomes.
Although stenting proximal rectal cancer may similarly be performed as a bridge to further therapy, stenting an obstructing distal rectal cancer is typically
not recommended because a stent at this level can cause chronic pain, tenesmus, and worse quality of life and can migrate
Two early trials established the benefits of adjuvant therapy over observation alone after curative resection of rectal cancer.